Technological Advances That Herald A Renaissance in Peptide Drug Discovery

October 15, 2020 11:00 AM - 12:00 PM

Webinar, click "live-stream" button to view

Add to Calendar 10/15/2020 11:00:56 AM 10/15/2020 12:00:56 PM Technological Advances That Herald A Renaissance in Peptide Drug Discovery

This forum will cover the area of therapeutic peptides and provide historical perspectives including the ups and downs of the field, current development trends, and future directions. We’ll discuss the role of artificial intelligence and machine learning in expanding the landscape of peptide drug discovery opportunities. And we’ll present a case study on targeting Pannexin 1 channels in disease. Questions are welcomed throughout the presentations and panel discussion.

Sponsored by the MassBio Drug Discovery forum working group.

NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.

Webinar, click "live-stream" button to view

This forum will cover the area of therapeutic peptides and provide historical perspectives including the ups and downs of the field, current development trends, and future directions. We’ll discuss the role of artificial intelligence and machine learning in expanding the landscape of peptide drug discovery opportunities. And we’ll present a case study on targeting Pannexin 1 channels in disease. Questions are welcomed throughout the presentations and panel discussion.

Sponsored by the MassBio Drug Discovery forum working group.

NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.

Director, Deloitte Centre for Health Solutions, Deloitte LLP
Karen established Deloitte UK’s Centre for Health Solutions in November 2011. The Centre is the independent research arm of Deloitte’s Life Sciences and Health Care (LSHC) practices. Its aim is to be a trusted source of relevant, timely and reliable insights on emerging trends, challenges and solutions. The Centre combines creative thinking, robust research and industry experience to develop evidence-based perspectives on some of the biggest and most challenging issues to help our clients to transform themselves and, importantly, benefit the patient. Recent life sciences research reports include Ten years on: Measuring the return from pharmaceutical innovation 2019; and our series of reports on how AI is transforming the biopharma value chain (Intelligent drug discovery - Powered by AI, Intelligent clinical trials - Transforming through AI enablement and Intelligent drug supply chain- Creating value from AI. Recent healthcare focused reports include: Closing the digital gap: Shaping the future of UK healthcare, Realising digital first primary care with the third report in the series on digital transformation of healthcare, focussed on seven European countries, published on 10 September. Karen is a member of the Institute of Chartered Public Finance and Accountants and has extensive experience in leading research into healthcare and life-science issues in the UK and internationally. In 2002, Karen received an OBE for her work on Health Value for Money Audit work. For past eight years Karen has been a Non-Executive Director at Dartford and Gravesham NHS Trust where she chairs the Audit Committee.